← SynDRA
OMBITASVIR
SynDRA canonical compound SYN0037831 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | HCV inhibitor |
| Indication | hepatitis C |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
Drug classes
- Hepatitis C Virus NS5A Inhibitor
- UGT1A1 Inhibitors
ATC classes
Cross-references
Synonyms
- ombitasvir hydrate
- ombitasvir heminonahydrate
- ABT-267
- Ombitasvir component of technivie
- Ombitasvir component of viekirax
- HCV therapeutic, Abbott
- ABT 267
- ABT267
- CHEBI:85183
- VIEKIRAX COMPONENT OMBITASVIR
- ombitasvirum
- RefChem:168187
- DTXCID101513481
- Ombitasvir(ABT-267)
- Ombitasvir [INN]
- Ombitasvir [USAN:INN]
- UNII-2302768XJ8
- MFCD28386270
- OMBITASVIR [MI]
- Ombitasvir (USAN/INN)
- OMBITASVIR [USAN]
- Ombitasvir (ABT-267)
- OMBITASVIR [VANDF]
- OMBITASVIR [WHO-DD]
- SCHEMBL8542284
- OMBITASVIR [ORANGE BOOK]
- GTPL11272
- GLXC-07662
- EX-A5846
- BDBM50453112
- EBC-27503
- s5403
- AKOS025396425
- CCG-270561
- CS-5330
- compound 38 [PMID: 24400777]
- NCGC00510316-01
- NCGC00510316-02
Look up OMBITASVIR in the interactive SynDRA portal →